Question 1

Has Sheryl Ziegler received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $20,977 in general payments to Sheryl Ziegler across 63 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Sheryl Ziegler did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Sheryl Ziegler come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Bristol Myers Squibb	7	$17,806
Tosoh Bioscience, Inc.	2	$1,918
Sanofi	7	$215
Athenex Pharmaceutical Division, LLC	1	$175
AstraZeneca(2 entities)	6	$127
Amgen	2	$124
Novartis	7	$110
Lilly USA, LLC	3	$62
Exelixis Inc.	1	$57
E.r. Squibb & Sons, L.L.C.	3	$55
Johnson & Johnson	3	$40
Beigene USA, Inc.	2	$34
Merck	2	$31
Eisai Inc.	2	$28
Gilead(2 entities)	2	$27
Seagen Inc.	2	$26
Genentech USA, Inc.	2	$25
Clovis Oncology, Inc.	1	$15
Helsinn Therapeutics (U.S.), Inc.	1	$15
Pharmacyclics LLC, An Abbvie Company	1	$14
Astellas Pharma US Inc	1	$14
Bayer	1	$13
Pfizer	1	$13
Karyopharm Therapeutics Inc.	1	$12
Teva Pharmaceuticals USA, Inc.	1	$11
EMD Serono, Inc.	1	$11

Sheryl Ziegler

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Other hematology & oncology in Newburgh